Long-lasting changes of rat blood pressure to vasoconstrictors and vasodilators induced by nitric oxide donor infusion: Involvement of potassium channels

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 1, 1999, Pages 380-387

  Da Silva Santos, José Eduardo ^a   Assreuy, Jamil ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; ACETYLCHOLINE; ANGIOTENSIN; ANGIOTENSIN I; BRADYKININ; GLIBENCLAMIDE; ILOPROST; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; POTASSIUM CHANNEL; TETRYLAMMONIUM; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; VASODILATATION; VASOMOTOR REFLEX;

ANIMALS; BLOOD PRESSURE; FEMALE; MALE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PENICILLAMINE; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, WISTAR; S-NITROSO-N-ACETYLPENICILLAMINE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0033005445     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ca channel in airway smooth muscle by nitric oxide: Involvement of a nitrothiosylation mechanism? Am J Respir Cell Mol Biol 19:485-497.
2. Archer SL, Huang JM, Hampl V, Neslon DP, Shultz PJ and Weir EK (1994) Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 91:7573-7587.
3. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I and Busse R (1996) Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94:3341-3347.
4. Bolotina V, Najibi S, Palacino JJ, Pagano PJ and Cohen R (1994) Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature (Lond) 368:850-853.
5. Brandtzaeg, P (1996) Significance and pathogenesis of septic shock, in Pathophysiotogy of Septic Shock. Current Topics in Microbiology and Immunology (Rietschel ET and Wagner H eds) pp 16-37, Springer-Verlag, Berlin.
6. Buga GM, Griscavage JM, Rogers NE and Lgnarrc LJ (1993) Negative feedback regulation of endothelial cell function by nitric oxide. Cire Res 73:808-812.
7. Chen G, Suzuki H and Weston AH (1988) Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol 95:1165-1174.
8. Davisson RL, Bates JN, Johnson AK and Lewis SJ (1996) Use-dependent loss of acetylcholine-and bradykinin-mediated vasodilation after nitric oxide synthase inhibition. Evidence for preformed stores of nitric oxide-containing factors in vascular endothelial cells. Hypertension 28:354-360.
9. Edwards G and Weston AH (1998) Endothelium-derived hyperpolarizing factor - A critical appraisal. Prog Drug Res 50:109-133.
10. Field L, Dilts RV, Ravichandran R, Lenhert PG and Carnahan GE (1978) An unusually stable thionitrite from N-acetyl-D,L-penicillamine; X-ray crystal and molecular structure of 2-(acetylamino)-2-carboxy-1,1-dimethylethyl thionitrite. J Chem Soc Comm 249-250.
11. Fleming I, Julou-Schaeffer G, Gray GA, Parratt JR and Stoclet J (1991) Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br J Pharmacol 103: 1047-1052.
12. Garland CJ, Plane F, Kemp BK and Cocks TM (1995) Endothelium-dependent hyperpolarization: A role in the control of vascular tone. Trends Pharmacol Sci 16:23-30.
13. Granger DL, Hibbs JB, Perfect JR and Durack DT (1990) Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J Clin Invest 85:264-273.
14. Gratton JP, Maurice MC, Rae GA and D'Orleans-Juste P (1995) Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats. Am J Hypertens 8:1121-1127.
15. Gray GA, Julou-Schaeffer G, Oury K, Fleming I, Parratt JR and Stoclet JC (1990) An L-arginine-derived factor mediates endotoxin-induced vascular hyposensitivity to calcium. Eur J Pharmacol 191:89-92.
16. Gray GA, Schoot C, Julou-Schaeffer G, Fleming I, Parratt JR and Stoclet JC (1991) The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 103:1218-1224.
17. + channels underlies relaxation to bacterial lipopolysaccharide in rat aorta. Biochem Biophys Res Commun 224:184-190.
18. + channel in the pancreatic β-cell. FEBS Lett 319:128-132.
19. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR and Stoclet JC (1990) Loss of vascular responsiveness induced by endotoxin involves the L-arginine pathway. Am JPhysiol 259:H1038-H1043.
20. Katsuki S, Arnold W, Mittal C and Murad F (1977) Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 3:23-35.
21. Ca in smooth muscle cells isolated from the rat mesenteric artery. Br J Pharmacol 124:1131-1140.
22. Mombouli J-V and Vanhoutte PM (1997) Endothelium-derived hyperpolarizing factor(s): Updating the unknown. Trends Pharmacol Sci 18:252-256.
23. Moncada S, Gryglewski RJ, Bunting S and Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (Lond) 263:663-665.
24. Moncada S, Palmer RMJ and Higgs EA (1991) Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142.
25. Mulder MF, Van Lambalgen AA, Huisman E, Visser JJ, Van Den Bos GC and Thijs LG (1994) Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats. Am J Physiol 268:H1558-H1564.
26. Okabe K, Kitamura K and Kuriyama H (1987) Features of 4-aminopyridine sensitive outward current observed in single smooth muscle cells from the rabbit pulmonary artery. Pflügers Arch 409:561-568.
27. Petersson J, Zygmunt PM and Hogestatt ED (1997) Characterisation of the potassium channels involved in EDHF-mediated relaxation in cerebral arteries. Br J Pharmacol 120:1344-13444.
28. Price JM, Baker CH and Bond RF (1997) Calcium-activated potassium channel-mediated arteriolar relaxation during endotoxic shock. Shock 7:294-299.
29. K(A) channels by cysteine oxidation. Nature (Lond) 352:711-714.
30. Snyder SH and Bredt DS (1992) Biological roles of nitric oxide. Sci. Am. 266:68-77.
31. Stamler JS (1994) Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell 78:931-936.
32. Tare M, Parkington HC, Coleman HA, Neild TO and Dusting GJ (1990) Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from endothelium. Nature (London) 346:69-71.
33. Taylor SG and Weston AH (1988) Endothelium-derived hyperpolarizing factor: A new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci 9:272-274.
34. + channels in smooth muscle cells. J Gen Physiol 110:35-44.
35. Wu CC, Chen SJ and Yen MH (1998) Nitric oxide-independent activations of soluble guanylyl cyclase contributes to endotoxin shock in rats. Am J Physiol 276:H1148-H1157.
36. Wu CC, Ruetten H and Thiemermann C (1996) Comparison of the effects of aminoguanidine and N-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat. Eur J Pharmocol 300:99-104.
37. + channels Proc Natl Acad Sci USA 93:10489-10494.
38. ca channels antagonizes NO-induced relaxation in pulmonary artery. Am J Physiol 272:H904-H912.